Merck to Acquire Imago BioSciences, Inc.

Merck, known as MSD outside of the United States and Canada, and Imago BioSciences, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago for $36.00 per share in cash for an approximate total equity value of $1.35 billion. Read more.